Q1 2025 · 13F-HR
M28 Capital Management LPholdings as filed
Filed 2025-05-14 · accession 0000902664-25-002321
$73.0M
Reported value
11
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $45.8M | 62.7% | 5,664,548 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $6.4M | 8.73% | 161,600 | Common | SOLE |
| 00534A102 | IVVD | INVIVYD INC | $5.6M | 7.67% | 9,248,250 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $4.2M | 5.74% | 121,200 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $2.6M | 3.53% | 385,680 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $2.4M | 3.34% | 55,200 | Common | SOLE |
| 35168W103 | GUTS | FRACTYL HEALTH INC | $2.2M | 3.03% | 1,856,117 | Common | SOLE |
| N71542109 | PRQR | PROQR THRAPEUTICS N V | $1.4M | 1.86% | 1,019,498 | Common | SOLE |
| 231269309 | CRIS | CURIS INC | $1.1M | 1.50% | 521,059 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $858,676 | 1.18% | 67,400 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $521,982 | 0.72% | 185,100 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.